Bedaquiline

Aug 14, 2019

FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis

Aug 14, 2019

FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs

Aug 14, 2019

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

Jun 06, 2019

FDA Advisory Committee Votes Favorably on the Question of the Effectiveness and Safety of Pretomanid in Combination with Bedaquiline and Linezolid for Treatment of Highly Drug-Resistant Forms of Tuberculosis

Apr 18, 2019

TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis (TB)

Aug 24, 2018

Global Tuberculosis (TB) Drugs/Therapeutics Market, 2018-2025 - Key Players are J&J Services, Lupin, Pfizer, Novartis, Macleods Pharmaceuticals, and Otsuka Pharmaceutical

Jul 18, 2018

TB Drugs Market Size Worth $1.38 Billion by 2025 | CAGR: 5.2%: Grand View Research, Inc.

Jul 04, 2018

The global tuberculosis drugs/therapeutics (TB) market size is expected to reach USD 1.38 billion by 2025